Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7761)
All Articles published online
|
Publishing Process of This Article
|
Jun 28, 2014 (publication date) through Apr 25, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Wang XY, Chen HS. Emerging antivirals for the treatment of hepatitis B. World J Gastroenterol 2014; 20(24): 7707-7717 [PMID: 24976708 DOI: 10.3748/wjg.v20.i24.7707] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v20/i24/7707.htm |
| Number | Citing Articles |
| 1 |
Lemonica Koumbi. Current and future antiviral drug therapies of hepatitis B chronic infection. World Journal of Hepatology 2015; 7(8): 1030-1040 doi: 10.4254/wjh.v7.i8.1030
|
| 2 |
Ya-Juan Wang., Li Yang, Jian-Ping Zuo. Recent developments in antivirals against hepatitis B virus. Virus Research 2016; 213: 205 doi: 10.1016/j.virusres.2015.12.014
|
| 3 |
Forough Golsaz-Shirazi, Hamed Mohammadi, Mohammad Mehdi Amiri, Jalal Khoshnoodi, Gholam Ali Kardar, Mahmood Jeddi-Tehrani, Fazel Shokri. Localization of immunodominant epitopes within the “a” determinant of hepatitis B surface antigen using monoclonal antibodies. Archives of Virology 2016; 161(10): 2765 doi: 10.1007/s00705-016-2980-y
|
| 4 |
Patrizia Caligiuri, Rita Cerruti, Giancarlo Icardi, Bianca Bruzzone. Overview of hepatitis B virus mutations and their implications in the management of infection. World Journal of Gastroenterology 2016; 22(1): 145-154 doi: 10.3748/wjg.v22.i1.145
|
| 5 |
Quentin Osseman, Lara Gallucci, Shelly Au, Christian Cazenave, Elodie Berdance, Marie-Lise Blondot, Aurélia Cassany, Dominique Bégu, Jessica Ragues, Cindy Aknin, Irina Sominskaya, Andris Dishlers, Birgit Rabe, Fenja Anderson, Nelly Panté, Michael Kann. The chaperone dynein LL1 mediates cytoplasmic transport of empty and mature hepatitis B virus capsids. Journal of Hepatology 2018; 68(3): 441 doi: 10.1016/j.jhep.2017.10.032
|
| 6 |
Priyanka Kumar, Catherine Freeland, Sierra Bodor, Sean Farrell, Chari Cohen, Rosemary Frasso. Needs of Individuals Living With Hepatitis Delta Virus and Their Caregivers, 2016–2019. Preventing Chronic Disease 2020; 17 doi: 10.5888/pcd17.200324
|
| 7 |
Latavia Singh, Sunaina Indermun, Mershen Govender, Pradeep Kumar, Lisa du Toit, Yahya Choonara, Viness Pillay. Drug Delivery Strategies for Antivirals against Hepatitis B Virus. Viruses 2018; 10(5): 267 doi: 10.3390/v10050267
|
| 8 |
Claire Pierra Rouviere, Cyril B. Dousson, John E. Tavis. HBV replication inhibitors. Antiviral Research 2020; 179: 104815 doi: 10.1016/j.antiviral.2020.104815
|
| 9 |
N HASSAN, FU AMIN, K BASHIR, M IRSHAD, S JAMIL, N MUNAWAR, H HAQQANI, H SHABIR, MA KHAN. ANTIVIRAL RESPONSE OF DRUGS USED AGAINST HBV PATIENTS OF KHYBER PAKHTUNKHWA, PAKISTAN. Bulletin of Biological and Allied Sciences Research 2023; 2023(1): 49 doi: 10.54112/bbasr.v2023i1.49
|
| 10 |
Sobia Manzoor, Muhammad Saalim, Muhammad Imran, Saleha Resham, Javed Ashraf. Hepatitis B virus therapy: What’s the future holding for us?. World Journal of Gastroenterology 2015; 21(44): 12558-12575 doi: 10.3748/wjg.v21.i44.12558
|
| 11 |
Apostolos Beloukas, Anna Maria Geretti. Antimicrobial Drug Resistance. 2017; : 1227 doi: 10.1007/978-3-319-47266-9_26
|
| 12 |
Joseph Yoo, Hie-Won Hann, Robert Coben, Mitchell Conn, Anthony DiMarino. Update Treatment for HBV Infection and Persistent Risk for Hepatocellular Carcinoma: Prospect for an HBV Cure. Diseases 2018; 6(2): 27 doi: 10.3390/diseases6020027
|
| 13 |
Li Yang, Ya-Juan Wang, Hai-Jun Chen, Li-Ping Shi, Xian-Kun Tong, Yang-Ming Zhang, Gui-Feng Wang, Wen-Long Wang, Chun-Lan Feng, Pei-Lan He, Yi-Bin Xu, Meng-Ji Lu, Wei Tang, Fa-Jun Nan, Jian-Ping Zuo. Effect of a hepatitis B virus inhibitor, NZ-4, on capsid formation. Antiviral Research 2016; 125: 25 doi: 10.1016/j.antiviral.2015.11.004
|
| 14 |
Bianca W. Chang, Aung Kaung, Lori Robbins, Tram T. Tran. Hepatitis B: Working Towards a Cure. Current Gastroenterology Reports 2015; 17(9) doi: 10.1007/s11894-015-0460-2
|
| 15 |
Antonio Gonçalves, Annabelle Lemenuel‐Diot, Valérie Cosson, Yuyan Jin, Sheng Feng, Qingyan Bo, Jérémie Guedj. What drives the dynamics of HBV RNA during treatment?. Journal of Viral Hepatitis 2021; 28(2): 383 doi: 10.1111/jvh.13425
|
| 16 |
Abhasnee Sobhonslidsuk, Jirachaya Wanichanuwat, Pawin Numthavaj, Areepan Sophonsritsuk, Supanna Petraksa, Alongkorn Pugasub, Paisan Jittorntam, Anucha Kongsomgan, Sittiruk Roytrakul, Bunyong Phakdeekitcharoen. Nucleotide Analogue-Related Proximal Renal Tubular Dysfunction during Long-Term Treatment of Chronic Hepatitis B: A Cross-Sectional Study. Gastroenterology Research and Practice 2016; 2016: 1 doi: 10.1155/2016/2952635
|
| 17 |
Elena Lomonosova, John E. Tavis. Hepatitis B Virus. Methods in Molecular Biology 2017; 1540: 179 doi: 10.1007/978-1-4939-6700-1_14
|
| 18 |
Haiyong Jia, Diwakar Rai, Peng Zhan, Xuwang Chen, Xuemei Jiang, Xinyong Liu. Recent advance of the hepatitis B virus inhibitors: a medicinal chemistry overview. Future Medicinal Chemistry 2015; 7(5): 587 doi: 10.4155/fmc.15.19
|
| 19 |
Dejuan Sun, Lingjuan Zhu, Dahong Yao, Lixia Chen, Leilei Fu, Liang Ouyang. Recent progress in potential anti-hepatitis B virus agents: Structural and pharmacological perspectives. European Journal of Medicinal Chemistry 2018; 147: 205 doi: 10.1016/j.ejmech.2018.02.001
|
| 20 |
Andrea Luk, Qiudi Jiang, Katerina Glavini, Miriam Triyatni, Na Zhao, Tomas Racek, Yonghong Zhu, Joseph F. Grippo. A Single and Multiple Ascending Dose Study of Toll‐Like Receptor 7 Agonist (RO7020531) in Chinese Healthy Volunteers. Clinical and Translational Science 2020; 13(5): 985 doi: 10.1111/cts.12791
|
| 21 |
Jianghua Wang, Haiying Zhang, Yingjun Zhang, Dong Jiang, Jing Li, Siegfried Goldmann, Qingyun Ren, Ran Fei, Xueyan Wang, Lai Wei. Influences on viral replication and sensitivity to GLS4, a HAP compound, of naturally occurring T109/V124 mutations in hepatitis B virus core protein. Journal of Medical Virology 2017; 89(10): 1804 doi: 10.1002/jmv.24830
|
| 22 |
Naoki Takizawa, Manabu Yamasaki. Current landscape and future prospects of antiviral drugs derived from microbial products. The Journal of Antibiotics 2018; 71(1): 45 doi: 10.1038/ja.2017.115
|
| 23 |
Mirjam B Zeisel, Julie Lucifora, William S Mason, Camille Sureau, Jürgen Beck, Massimo Levrero, Michael Kann, Percy A Knolle, Monsef Benkirane, David Durantel, Marie-Louise Michel, Brigitte Autran, François-Loïc Cosset, Hélène Strick-Marchand, Christian Trépo, Jia-Horng Kao, Fabrice Carrat, Karine Lacombe, Raymond F Schinazi, Françoise Barré-Sinoussi, Jean-François Delfraissy, Fabien Zoulim. Towards an HBV cure: state-of-the-art and unresolved questions—report of the ANRS workshop on HBV cure. Gut 2015; 64(8): 1314 doi: 10.1136/gutjnl-2014-308943
|
| 24 |
Wei Xuan, Dandan Song, Youyou Yan, Ming Yang, Yan Sun, Nicoletta Guaragnella. A Potential Role for Mitochondrial DNA in the Activation of Oxidative Stress and Inflammation in Liver Disease. Oxidative Medicine and Cellular Longevity 2020; 2020: 1 doi: 10.1155/2020/5835910
|
| 25 |
Abhasnee Sobhonslidsuk, Pawin Numthavaj, Jirachaya Wanichanuwat, Areepan Sophonsritsuk, Supanna Petraksa, Alongkorn Pugasub, Paisan Jittorntam, Anucha Kongsomgan, Sittiruk Roytrakul, Bunyong Phakdeekitcharoen. Reversal of Proximal Renal Tubular Dysfunction after Nucleotide Analogue Withdrawal in Chronic Hepatitis B. BioMed Research International 2017; 2017: 1 doi: 10.1155/2017/4327385
|
| 26 |
Ibrahim Halil Bahcecioglu, Abdurrahman Sahin. Treatment of Delta Hepatitis: Today and in the Future - A review. Infectious Diseases 2017; 49(4): 241 doi: 10.1080/23744235.2016.1271998
|
| 27 |
Hiroki Nishikawa, Norihiro Nishijima, Hirayuki Enomoto, Azusa Sakamoto, Akihiro Nasu, Hideyuki Komekado, Takashi Nishimura, Ryuichi Kita, Toru Kimura, Hiroko Iijima, Shuhei Nishiguchi, Yukio Osaki. A predictive model for carcinogenesis in patients with chronic hepatitis B undergoing entecavir therapy and its validation. Medicine 2016; 95(36): e4832 doi: 10.1097/MD.0000000000004832
|
| 28 |
Altaf Dawood, Syed Abdul Basit, Mahendran Jayaraj, Robert G. Gish. Drugs in Development for Hepatitis B. Drugs 2017; 77(12): 1263 doi: 10.1007/s40265-017-0769-2
|
| 29 |
Uma S. Singh, Varughese A. Mulamoottil, Chung K. Chu. 2′‐Fluoro‐6′‐methylene carbocyclic adenosine and its phosphoramidate prodrug: A novel anti‐HBV agent, active against drug‐resistant HBV mutants. Medicinal Research Reviews 2018; 38(3): 977 doi: 10.1002/med.21490
|
| 30 |
Amal Kumar Dhara, Amit Kumar Nayak. Viral Infections and Antiviral Therapies. 2023; : 3 doi: 10.1016/B978-0-323-91814-5.00025-8
|